The FDA (U.S. Food and Drug Administration) has officially cleared TMS therapy (Transcranial Magnetic Stimulation) for use in adolescents and young adults ages 15–21 who are struggling with depression and haven’t improved enough with antidepressant medications.

This is big news for families searching for safe, non-drug options. Until now, TMS therapy was mainly available only for adults with depression. With this new clearance, clinics like TMS Institute of Arizona can offer TMS as an additional treatment option for teens and young adults.

Why This Matters

Depression in teens is on the rise. Research shows that up to 1 in 5 adolescents will experience a major depressive episode before adulthood. Unfortunately, many struggle to stay on medications or don’t get the results they need. In fact, as many as 60% stop taking their prescriptions due to side effects or other challenges.

That’s where TMS therapy comes in. TMS is:

  • Non-invasive – no surgery or anesthesia required.
  • Medication-free – works without adding new prescriptions.
  • Quick – each session lasts about 20 minutes.
  • Well-tolerated – the most common side effect is mild discomfort on the scalp early in treatment.

Studies show that TMS can help improve mood, and results may last for up to six months.

How TMS Works

TMS uses gentle magnetic pulses to stimulate areas of the brain linked to mood regulation. The treatment helps “re-activate” parts of the brain that are underactive in depression.

At TMS Institute of Arizona, treatments are done in a comfortable office setting. Patients are awake the entire time and can return to school, work, or activities right after each session.

Insurance Coverage Expanding

The good news doesn’t stop there—many major insurance companies now cover TMS for adolescents, including Humana, Aetna, Cigna, BlueCross BlueShield (some states), and even certain Medicaid programs like California’s Medi-Cal. This means treatment is becoming more accessible to families who need it.

A Message from Dr. Ruchir P. Patel

Dr. Patel, Medical Director and owner of TMS Institute of Arizona, shared his thoughts on the FDA’s decision:

“I have seen lives completely transformed by TMS therapy — patients who had lost hope are now thriving. It’s nothing short of life-changing. With this new FDA clearance, we can bring this proven treatment to an entirely new group of young people. It’s thrilling to offer something so effective, safe, and non-drug to teens and young adults who desperately need more options. At the TMS Institute of Arizona, we are proud to lead the way with MagVenture technology and deliver real hope to families.”

Moving Forward

For many families, this news represents a turning point. Adolescents who once felt out of options now have access to a treatment that is safe, effective, and doesn’t rely on daily medications.

If your teen or young adult has been struggling with depression, contact TMS Institute of Arizona to learn whether TMS therapy may be the right option.